MedTrace Logo

Propolis Effects in Patients With Chronic Kidney Disease

NCT02766036 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-05-03

No results posted yet for this study

Summary

The aim of this study is to determine the impact of Propolis on proteinuria reduction and protection of the glomerular filtration rate in chronic renal failure patients.

Conditions

  • Chronic Kidney Diseases

Interventions

DRUG

Propolis

Patients will receive 500 mg / day of the propolis extract in the form of tablets split in two daily doses

DRUG

Placebo

Patients will receive 500 mg / day of the placebo in the form of tablets split in two daily doses

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • General Hospital · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766036 on ClinicalTrials.gov